Want to join the conversation?
$DVA 2Q15 Call: Solid results in Q4 for both Kidney Care and HCP. We’ve once again exceeded the Medicare fee-for-service benchmark on all metrics. So the clinical outcomes for both Kidney Care and Healthcare Partners compare very favorably national averages, which means healthier patients, higher patient satisfaction and savings to taxpayers.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.